Evolución y salud: evolución experimental y epidemiología
EVOSALUD
![Foto de Evolución y salud: evolución experimental y epidemiología](/img/grupo.png)
![Foto de University of California, San Francisco](/img/noimage_org.png)
University of California, San Francisco
San Francisco, Estados UnidosPublicaciones en colaboración con investigadores/as de University of California, San Francisco (8)
2018
-
Hsp90 shapes protein and RNA evolution to balance trade-offs between protein stability and aggregation
Nature Communications, Vol. 9, Núm. 1
2015
-
Genomic epidemiology of multidrug-resistant mycobacterium tuberculosis during transcontinental spread
Journal of Infectious Diseases, Vol. 212, Núm. 2, pp. 302-310
2013
-
Hsp90 Inhibitors Exhibit Resistance-Free Antiviral Activity against Respiratory Syncytial Virus
PLoS ONE, Vol. 8, Núm. 2
-
Out-of-Africa migration and Neolithic coexpansion of Mycobacterium tuberculosis with modern humans
Nature Genetics, Vol. 45, Núm. 10, pp. 1176-1182
2012
-
Beijing sublineages of Mycobacterium tuberculosis differ in pathogenicity in the guinea pig
Clinical and Vaccine Immunology, Vol. 19, Núm. 8, pp. 1227-1237
2007
-
Evolutionary constraints on chaperone-mediated folding provide an antiviral approach refractory to development of drug resistance
Genes and Development, Vol. 21, Núm. 2, pp. 195-205
2004
-
Genetic Variability of Hepatitis C Virus Non-Structural Protein 3 and Virus-Specific CD8+ Response in Patients with Chronic Hepatitis C
Journal of Medical Virology, Vol. 72, Núm. 4, pp. 575-585
1996
-
Genetic lesions associated with Muller's ratchet in an RNA virus
Journal of Molecular Biology, Vol. 264, Núm. 2, pp. 255-267